INDOCYANINE GREEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Indocyanine Green, and what generic alternatives are available?
Indocyanine Green is a drug marketed by Renew Pharms and is included in one NDA.
The generic ingredient in INDOCYANINE GREEN is indocyanine green. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the indocyanine green profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Indocyanine Green
A generic version of INDOCYANINE GREEN was approved as indocyanine green by RENEW PHARMS on November 21st, 2007.
Summary for INDOCYANINE GREEN
Recent Clinical Trials for INDOCYANINE GREEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Cancer Center, China | N/A |
OnLume Inc. | Early Phase 1 |
University of Wisconsin, Madison | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for INDOCYANINE GREEN
Anatomical Therapeutic Chemical (ATC) Classes for INDOCYANINE GREEN
Paragraph IV (Patent) Challenges for INDOCYANINE GREEN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SPY AGENT GREEN KIT | For Injection | indocyanine green | 25 mg/vial | 211580 | 1 | 2022-11-28 |
US Patents and Regulatory Information for INDOCYANINE GREEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Renew Pharms | INDOCYANINE GREEN | indocyanine green | INJECTABLE;INJECTION | 040811-001 | Nov 21, 2007 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |